In MSA, FDG-PET demonstrates characteristic nigrostriatal and olivocerebellar hypometabolism; in PSP, frontal lobe hypometabolism, and tau-PET confirms the underlying tauopathy. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.